Thomas Riemer

1.2k total citations
46 papers, 787 citations indexed

About

Thomas Riemer is a scholar working on Cardiology and Cardiovascular Medicine, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Thomas Riemer has authored 46 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 14 papers in Psychiatry and Mental health and 13 papers in Pharmacology. Recurrent topics in Thomas Riemer's work include Treatment of Major Depression (11 papers), Blood Pressure and Hypertension Studies (10 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Thomas Riemer is often cited by papers focused on Treatment of Major Depression (11 papers), Blood Pressure and Hypertension Studies (10 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Thomas Riemer collaborates with scholars based in Germany, Switzerland and Italy. Thomas Riemer's co-authors include Reinhold Kreutz, Engi Algharably, Tomasz J. Guzik, Aleksander Prejbisz, Ji‐Guang Wang, Michel Azizi, Andrzej Januszewicz, Michel Burnier, Piotr Dobrowolski and Alexandre Persu and has published in prestigious journals such as Scientific Reports, Hypertension and The American Journal of Cardiology.

In The Last Decade

Thomas Riemer

37 papers receiving 765 citations

Peers

Countries citing papers authored by Thomas Riemer

Since Specialization

Citations

This map shows the geographic impact of Thomas Riemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Riemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Riemer more than expected).

Fields of papers citing papers by Thomas Riemer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Riemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Riemer. The network helps show where Thomas Riemer may publish in the future.

Co-authorship network of co-authors of Thomas Riemer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Riemer. A scholar is included among the top collaborators of Thomas Riemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Riemer. Thomas Riemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis 2025 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·(unknown), (unknown), (unknown), Michael Traub, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Andrea Lohse, Felix Bermpohl, Thomas Riemer, Tomislav Majić	0
2	Calcium channel blockers and mental health: a comprehensive meta-analysis of psychiatric adverse events in double-blind randomized controlled trials 2025 ·Journal of Hypertension ·(unknown), (unknown), Reinhold Kreutz, Thomas Riemer	0
3	Safety of concomitant use of oral anticoagulants and antidiabetic drugs: a systematic review of observational studies 2025 ·Expert Opinion on Drug Metabolism & Toxicology ·(unknown), Wanqi Wang, (unknown), Thomas Riemer, Antonios Douros	0
4	Effectiveness and safety of concomitant use of direct oral anticoagulants and antiarrhythmic drugs: a systematic review of observational studies 2025 ·European Journal of Clinical Pharmacology ·(unknown), (unknown), Thomas Riemer, Antonios Douros	0
5	The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics 2025 ·Journal of Psychopharmacology ·Tomislav Majić, Timo Torsten Schmidt, (unknown), Peter Gasser, William A. Richards, Thomas Riemer, Ricarda Evens	0
6	Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis 2024 ·Scientific Reports ·(unknown), Tomislav Majić, (unknown), Engi Algharably, Reinhold Kreutz, Thomas Riemer	6
7	Psychiatric adverse events of calcium channel blockers – protocol for a systematic review and meta-analysis 2024 ·(unknown), (unknown), Reinhold Kreutz, Thomas Riemer	1
8	Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls 2024 ·Scientific Reports ·(unknown), Tomislav Majić, (unknown), Thomas Riemer	1
9	Venlafaxine’s therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis 2023 ·Psychopharmacology ·(unknown), Christoph Hiemke, (unknown), Ursula Havemann‐Reinecke, Gudrun Hefner, Andreas Menke, Rainald Mößner, Thomas Riemer, Maike Scherf‐Clavel, Georgios Schoretsanitis, Gerhard Gründer, (unknown)	8
10	Therapeutic Reference Range for Olanzapine in Schizophrenia 2023 ·The Journal of Clinical Psychiatry ·(unknown), Christoph Hiemke, Niels Bergemann, Karin Egberts, (unknown), Manfred Gerlach, Ursula Havemann‐Reinecke, (unknown), Thomas Riemer, Georgios Schoretsanitis, Manfred Uhr, Gerald Zernig, Gerhard Gründer, (unknown)	8
11	Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis 2022 ·Pharmacopsychiatry ·(unknown), Christoph Hiemke, H.‐W. Clement, Andreas Conca, (unknown), Frank Faltraco, Vincenzo De Florio, (unknown), Ursula Havemann‐Reinecke, (unknown), Espen Molden, Michael Paulzen, Thomas Riemer, Georgios Schoretsanitis, Gerhard Gründer	1
12	The therapeutic reference range for olanzapine revised – how to combine old and new findings 2022 ·Pharmacopsychiatry ·(unknown), Christoph Hiemke, N. Bergemann, M. Gerlach, Ursula Havemann‐Reinecke, (unknown), Thomas Riemer, Georgios Schoretsanitis, Manfred Uhr, Gerald Zernig, Gerhard Gründer, (unknown)	1
13	Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range 2022 ·Pharmacopsychiatry ·(unknown), Christoph Hiemke, Andreas Conca, Jan Engelmann, M. Gerlach, Ursula Havemann‐Reinecke, Gudrun Hefner, Vincenzo De Florio, (unknown), Klaus Lieb, Margareta Reis, Thomas Riemer, (unknown), Georgios Schoretsanitis, Gerald Zernig, Gerhard Gründer, (unknown)	1
14	Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors 2022 ·Frontiers in Psychiatry ·(unknown), (unknown), Gerhard Gründer, Christoph Hiemke, (unknown), Reinhold Kreutz, Thomas Riemer	12
15	Do β-Blockers Cause Depression? 2021 ·Hypertension ·Thomas Riemer, (unknown), Engi Algharably, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kristian Wachtell, Tomislav Majić, (unknown), Reinhold Kreutz	34
16	Neuropsychological Functioning in Users of Serotonergic Psychedelics – A Systematic Review and Meta-Analysis 2021 ·Frontiers in Pharmacology ·(unknown), Thomas Riemer, (unknown), Reinhold Kreutz, Tomislav Majić	13
17	Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic Reviews 2021 ·Frontiers in Psychiatry ·(unknown), (unknown), (unknown), Thomas Riemer, (unknown), Christoph Hiemke, Gerhard Gründer	20
18	Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19 2020 ·Cardiovascular Research ·Reinhold Kreutz, Engi Algharably, Michel Azizi, Piotr Dobrowolski, Tomasz J. Guzik, Andrzej Januszewicz, Alexandre Persu, Aleksander Prejbisz, Thomas Riemer, Ji‐Guang Wang, Michel Burnier	248
19	Catechol-O-methyltransferase (COMT) Genotype Affects Age-Related Changes in Plasticity in Working Memory: A Pilot Study 2014 ·BioMed Research International ·Stephan Heinzel, Thomas Riemer, Stefanie Schulte, (unknown), Andreas Heinz, Michael A. Rapp	13
20	Pre- and early in-hospital procedures in patients with acute coronary syndromes: first results of the “German chest pain unit registry” 2012 ·Clinical Research in Cardiology ·Felix Post, Evangelos Giannitsis, Thomas Riemer, Lars S. Maier, Claus Schmitt, Burghard Schumacher, Gerd Heusch, Harald Mudra, Thomas Voigtländer, R Erbel, Harald Darius, Hugo A. Katus, Christian W. Hamm, Jochen Senges, Tommaso Gori, Thomas Münzel	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact